The BCL-ABL fusion gene, which has been identified as a crucial step in the pathogenesis of CML, encodes the fusion BCR-ABL1 protein, which possesses constitutive tyrosine kinase activity (3,4). The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.